• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

miR-630 通过靶向 KLF6 促进卵巢上皮性癌细胞的增殖和侵袭。

MiR-630 promotes epithelial ovarian cancer proliferation and invasion via targeting KLF6.

机构信息

Department of Gynecology, Zhangjiagang Hospital of Traditional Chinese Medicine Affiliated to Nanjing University of Chinese Medicine, Zhangjiagang, Jiangsu Province, China.

出版信息

Eur Rev Med Pharmacol Sci. 2017 Oct;21(20):4542-4547.

PMID:29131262
Abstract

OBJECTIVE

MicroRNAs play critical roles in post-translational gene expression. The current study was to investigate the effects of miR-630 in epithelial ovarian cancer.

PATIENTS AND METHODS

Thirty epithelial ovarian cancer tissue and thirty normal ovarian tissue samples were collected and were detected miR-630 expression level with qRT-PCR. MiR-630 mimics, inhibitors and negative controls were transfected into SKOV3 and Cell Counting Kit-8 (CCK-8) assay, and transwell experiment were performed to detect the proliferation rate and migration, respectively. The luciferase reporter assay was utilized to identify miR-630's target gene. Balb/c nude mice were utilized to verify the effect of miR-630 in vivo.

RESULTS

QRT-PCR showed a significantly high miR-630 expression in epithelial ovarian cancer relative to normal ovarian tissue. The miR-630 overexpression promoted epithelial ovarian cancer cell SKOV3 proliferation and migration. Krüppel-like factor 6 (KLF6) was predicted as the target of miR-630. In vivo study also verified that miR-630 overexpression stimulated ovarian cancer growth.

CONCLUSIONS

We propose that targeting miR-630 might be a promising therapeutic approach for ovarian cancer.

摘要

目的

微小 RNA 在翻译后基因表达中发挥着关键作用。本研究旨在探讨 miR-630 在卵巢上皮性癌中的作用。

患者与方法

收集 30 例卵巢上皮性癌组织和 30 例正常卵巢组织标本,采用 qRT-PCR 检测 miR-630 的表达水平。转染 miR-630 模拟物、抑制剂和阴性对照至 SKOV3 细胞,通过细胞计数试剂盒-8(CCK-8)检测增殖率,Transwell 实验检测迁移能力。采用荧光素酶报告基因实验鉴定 miR-630 的靶基因。利用 Balb/c 裸鼠体内实验验证 miR-630 的作用。

结果

qRT-PCR 显示 miR-630 在卵巢上皮性癌组织中表达显著升高。miR-630 的过表达促进了卵巢上皮性癌细胞 SKOV3 的增殖和迁移。Krüppel 样因子 6(KLF6)被预测为 miR-630 的靶基因。体内研究也验证了 miR-630 过表达刺激卵巢癌的生长。

结论

我们提出靶向 miR-630 可能是治疗卵巢癌的一种有前途的方法。

相似文献

1
MiR-630 promotes epithelial ovarian cancer proliferation and invasion via targeting KLF6.miR-630 通过靶向 KLF6 促进卵巢上皮性癌细胞的增殖和侵袭。
Eur Rev Med Pharmacol Sci. 2017 Oct;21(20):4542-4547.
2
MicroRNA-145 targets TRIM2 and exerts tumor-suppressing functions in epithelial ovarian cancer.微小RNA-145靶向TRIM2并在上皮性卵巢癌中发挥肿瘤抑制功能。
Gynecol Oncol. 2015 Dec;139(3):513-9. doi: 10.1016/j.ygyno.2015.10.008. Epub 2015 Oct 16.
3
MiR-200c-3p aggravates gastric cell carcinoma via KLF6.miR-200c-3p 通过 KLF6 加重胃癌细胞。
Genes Genomics. 2021 Nov;43(11):1307-1316. doi: 10.1007/s13258-021-01160-6. Epub 2021 Sep 15.
4
MicroRNA-191 promotes hepatocellular carcinoma cell proliferation by has_circ_0000204/miR-191/KLF6 axis.MicroRNA-191 通过 has_circ_0000204/miR-191/KLF6 轴促进肝癌细胞增殖。
Cell Prolif. 2019 Sep;52(5):e12635. doi: 10.1111/cpr.12635. Epub 2019 Jul 23.
5
Overexpressed miR-9 promotes tumor metastasis via targeting E-cadherin in serous ovarian cancer.高表达的 miR-9 通过靶向黏附分子 E-cadherin 促进浆液性卵巢癌的肿瘤转移。
Front Med. 2017 Jun;11(2):214-222. doi: 10.1007/s11684-017-0518-7. Epub 2017 May 4.
6
MicroRNA-125b Suppresses Ovarian Cancer Progression via Suppression of the Epithelial-Mesenchymal Transition Pathway by Targeting the SET Protein.微小RNA-125b通过靶向SET蛋白抑制上皮-间质转化途径来抑制卵巢癌进展。
Cell Physiol Biochem. 2016;39(2):501-10. doi: 10.1159/000445642. Epub 2016 Jul 7.
7
miR-106a-5p carried by tumor-derived extracellular vesicles promotes the invasion and metastasis of ovarian cancer by targeting KLF6.肿瘤来源的细胞外囊泡携带的 miR-106a-5p 通过靶向 KLF6 促进卵巢癌的侵袭和转移。
Clin Exp Metastasis. 2022 Aug;39(4):603-621. doi: 10.1007/s10585-022-10165-8. Epub 2022 Apr 21.
8
MicroRNA-490-3P targets CDK1 and inhibits ovarian epithelial carcinoma tumorigenesis and progression.微小 RNA-490-3P 靶向 CDK1 并抑制卵巢上皮性癌的发生和进展。
Cancer Lett. 2015 Jun 28;362(1):122-30. doi: 10.1016/j.canlet.2015.03.029. Epub 2015 Mar 25.
9
MiR-410 Acts as a Tumor Suppressor in Estrogen Receptor-Positive Breast Cancer Cells by Directly Targeting ERLIN2 via the ERS Pathway.微小RNA-410通过雌激素受体信号通路直接靶向内质网蛋白2,在雌激素受体阳性乳腺癌细胞中发挥肿瘤抑制作用。
Cell Physiol Biochem. 2018;48(2):461-474. doi: 10.1159/000491777. Epub 2018 Jul 17.
10
MicroRNA-137 suppresses tumor growth in epithelial ovarian cancer in vitro and in vivo.微小RNA-137在体外和体内均可抑制上皮性卵巢癌的肿瘤生长。
Mol Med Rep. 2015 Aug;12(2):3107-14. doi: 10.3892/mmr.2015.3756. Epub 2015 May 7.

引用本文的文献

1
Role of DNA methylation and non‑coding RNAs expression in pathogenesis, detection, prognosis, and therapy‑resistant ovarian carcinoma (Review).DNA甲基化和非编码RNA表达在卵巢癌发病机制、检测、预后及治疗抵抗中的作用(综述)
Mol Med Rep. 2025 Jun;31(6). doi: 10.3892/mmr.2025.13509. Epub 2025 Apr 4.
2
MicroRNA-630 alleviates inflammatory reactions in rats with diabetic kidney disease by targeting toll-like receptor 4.微小RNA-630通过靶向Toll样受体4减轻糖尿病肾病大鼠的炎症反应。
World J Diabetes. 2024 Mar 15;15(3):488-501. doi: 10.4239/wjd.v15.i3.488.
3
MiR-630 Promotes Radioresistance by Induction of Anti-Apoptotic Effect via Nrf2-GPX2 Molecular Axis in Head-Neck Cancer.
miR-630 通过 Nrf2-GPX2 分子轴诱导抗凋亡作用促进头颈部癌症的放射抵抗。
Cells. 2023 Dec 17;12(24):2853. doi: 10.3390/cells12242853.
4
Potential of miR-181a-5p and miR-630 as clinical biomarkers in NSCLC.miR-181a-5p 和 miR-630 作为 NSCLC 临床生物标志物的潜力。
BMC Cancer. 2023 Sep 12;23(1):857. doi: 10.1186/s12885-023-11365-5.
5
CircFAM114A2 inhibits the progression of hepatocellular carcinoma via miR-630/HHIP axis.环状 RNA FAM114A2 通过 miR-630/HHIP 轴抑制肝细胞癌的进展。
Cancer Med. 2023 Jun;12(11):12553-12568. doi: 10.1002/cam4.5894. Epub 2023 Apr 11.
6
Krüppel-like Factor 6 Suppresses the Progression of Pancreatic Cancer by Upregulating Activating Transcription Factor 3.Krüppel样因子6通过上调激活转录因子3抑制胰腺癌进展。
J Clin Med. 2022 Dec 27;12(1):200. doi: 10.3390/jcm12010200.
7
MUTYH and KLF6 gene expression fluctuations in tumor tissue and tumor margins tissues of colorectal cancer.结直肠癌肿瘤组织和肿瘤边缘组织中 MUTYH 和 KLF6 基因表达的波动。
J Egypt Natl Canc Inst. 2022 Dec 5;34(1):57. doi: 10.1186/s43046-022-00158-9.
8
CircCERS6 Suppresses the Development of Epithelial Ovarian Cancer Through Mediating miR-630/RASSF8.环状 RNA 细胞外囊泡来源的 circCERS6 通过调控 miR-630/RASSF8 抑制上皮性卵巢癌的进展。
Biochem Genet. 2022 Dec;60(6):2611-2629. doi: 10.1007/s10528-022-10227-2. Epub 2022 Jun 8.
9
The importance of miRNA-630 in human diseases with an especial focus on cancers.miRNA-630在人类疾病中的重要性,尤其关注癌症。
Cancer Cell Int. 2022 Mar 5;22(1):105. doi: 10.1186/s12935-022-02531-z.
10
Circular RNA MTO1 intercorrelates with microRNA-630, both associate with Enneking stage and/or pathological fracture as well as prognosis in osteosarcoma patients.环状 RNA MTO1 与 microRNA-630 相互关联,均与骨肉瘤患者的 Enneking 分期和/或病理性骨折以及预后相关。
J Clin Lab Anal. 2021 Nov;35(11):e23987. doi: 10.1002/jcla.23987. Epub 2021 Sep 20.